Home › Psoriasis › Kentucky
Psoriasis clinical trials in Kentucky
4 studies for Psoriasis are looking for participants at sites in Kentucky.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kentucky/Markey Cancer Center, Lexington
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Equity Medical - Bowling Green, Bowling Green
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Kentucky Advanced Medical Research LLC, Murray
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 3, 2026 · NCT06979453A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Louisville
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 9, 2026 · NCT07489885From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.